Skip Navigation
Skip to contents

SSBH 2026

Official SNS Channel
instagram X
Today : 2026.06.10

D -8

Symposium 1. New Perspectives on Antiresorptive Therapy
Day 2 (June 19, Fri) 11:05-12:20Room 1

  • Understanding Rebound Bone Resorption After Denosumab Discontinuation
    Albert Kim (University of Sydney, Australia)
  • Denosumab in Hemodialysis: Bone Benefits and Vascular Risks
    Tetsuya Seto (Washington University in St. Louis, USA)
  • Beyond Bones: Extra-Skeletal Effects of Antiresorptives
    Jeonghoon Ha (The Catholic University of Korea, Korea)

Symposium 2. Inter-Organ Crosstalk
Day 2 (June 19, Fri) 11:05-12:20Room 2

  • NNeuronal Involvement in Disease-Associated Muscle Wasting and Its Implications in the Treatment
    Minho Shong (KAIST, Korea)
  • A Systems Genetics Approach to Unlocking Natural Product Efficacy: The Host-Microbiome Axis in Muscle Wasting Syndromes
    Myungsuk Kim (KIST, Korea)
  • Schnurri-3: A Regulator Beyond Osteogenesis
    Ren Xu (Xiamen University, China)

Symposium 3. Keynote Symposium
Day 2 (June 19, Fri) 16:00-17:15Room 1

  • Macrophage Efferocytosis Control
    by Salt-inducible Kinases:
    Implications for Inflammation and
    Bone Destruction in Rheumatoid Arthritis
    Hong-Hee Kim (Seoul National University, Korea)
  • Osteoimmunology of Bone Metastasis: Osteoblasts as Orchestrators of Bone Marrow Immunity
    Serk In Park (Korea University, Korea)
  • Skeletal Complications of Immune Checkpoint Inhibitors: A New Challenge
    A Ram Hong (Chonnam National University, Korea)

Symposium 4. Optimizing Treatment Strategies with Anabolic Agents
Day 3 (June 20, Sat) 11:15-12:30Room 1

  • The Anabolic Trio: Comparative Review of Teriparatide, Abaloparatide, and Romosozumab
    Kosuke Ebina (Osaka University, Japan)
  • Cardiovascular Safety of Anabolics: Evidence, Controversies, and Real-World Implications
    Seong Hee Ahn (Inha University, Korea)
  • Anabolics in Long-Term Osteoporosis Treatment: Sequential and Combination Strategies
    Namki Hong (Yonsei University, Korea)

Symposium 5. Next-Generation Musculoskeletal Biology
Day 3 (June 20, Sat) 11:15-12:30Room 2

  • Skeletal Muscle Organoids to Model Exercise and Insulin Resistance 
    Shyh-Chang Ng (Chinese Academy of Sciences, China)
  • Bone-on-a-Chip and Osteochondral Tissue Models: Microphysiological Platforms for Skeletal Interfaces
    Junmin Lee (POSTECH, Korea)
  • High-Resolution Spatial Transcriptomics Reveals Distinct Cellular Niches and Aging Remodeling in Murine Bone Marrow
    Lutian Yao (The First Hospital of China Medical University, China)

Symposium 6. Transforming Bone Health with Artificial Intelligence and Deep Learning
Day 3 (June 20, Sat) 14:55-16:10Room 1

  • Precision Medicine in Osteoporosis: Applying AI in Predicting Treatment Response
    Kyoung Min Kim (Yonsei University, Korea)
  • Integrating Muscle and Bone Metrics for Improving Fracture Risk Assessment
    Sung Hye Kong (Seoul National University, Korea)
  • Screening for Osteoporosis and Skeletal Muscle Loss Using CT Images and X-Rays
    Keisuke Uemura (Osaka University, Japan)

Symposium 7. Space Biology
Day 3 (June 20, Sat) 14:55-16:10Room 2

  • Testing Novel Muscle Atrophy Drug Candidates on the International Space Station
    Junsoo Park (Yonsei University, Korea)
  • The Reduction in Physical Tactile Stimuli Due to Microgravity in Space Has a Significant Impact on Neuromuscular Function in
    C. elegans
    Atsushi Higashitani (Tohoku University, Japan)
  • Microgravity-Driven Musculoskeletal Alteration and Inter-Organ Crosstalk
    Hyeonwoo Kim (KAIST, Korea)

Luncheon Symposium 1
Day 2 (June 19, Fri) 12:20-12:35Room 1

  • Optimizing the Sequential Treatment Journey in Osteoporosis
    Beom-Jun Kim (University of Ulsan, Korea)
    Michael R McClung

Luncheon Symposium 2
Day 2 (June 19, Fri) 12:35-12:50Room 1

  • Evolving Clinical Meaning of BMD in Osteoporosis: Stoboclo
    Yun Kyung Jeon (Pusan National University, Korea)

Luncheon Symposium 3
Day 3 (June 20, Sat) 12:30-12:45Room 1

  • Efficacy & Safety from a Global Phase 3 Trial Including Korean: Obodence
    Hye-Sun Park (Yonsei University, Korea
Sponsors By

Korean Society for Bone and Mineral Research (KSBMR)

#1001, Hyundai Kirim Bldg, 42, Seocho-daero 78-gil, Seocho-gu, Seoul, 06626, Korea

T. +82-2-3473-2230~1 | E. ksbmr@ksbmr.org

Business Registration Number: 106-82-62498

Name of Representative: Sang Wan Kim

SSBH 2026 Secretariat (PLANDO)

#615, 220, Gonghang-daero, Gangseo-gu, Seoul, 07806, Republic of Korea

T. +82-2-6734-1007, 1016 | E. info@ssbh.co.kr